These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17101779)

  • 1. Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma.
    Burgermeister E; Chuderland D; Hanoch T; Meyer M; Liscovitch M; Seger R
    Mol Cell Biol; 2007 Feb; 27(3):803-17. PubMed ID: 17101779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma.
    Burgermeister E; Seger R
    Cell Cycle; 2007 Jul; 6(13):1539-48. PubMed ID: 17611413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1.
    Yao Z; Flash I; Raviv Z; Yung Y; Asscher Y; Pleban S; Seger R
    Oncogene; 2001 Nov; 20(52):7588-96. PubMed ID: 11753637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casein-kinase-II-dependent phosphorylation of PPARgamma provokes CRM1-mediated shuttling of PPARgamma from the nucleus to the cytosol.
    von Knethen A; Tzieply N; Jennewein C; Brüne B
    J Cell Sci; 2010 Jan; 123(Pt 2):192-201. PubMed ID: 20026644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
    Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
    Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-γ nuclear export.
    Khateeb J; Kiyan Y; Aviram M; Tkachuk S; Dumler I; Fuhrman B
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):449-58. PubMed ID: 22155455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skp2 regulates subcellular localization of PPARγ by MEK signaling pathways in human breast cancer.
    Cheng H; Meng J; Wang G; Meng Y; Li Y; Wei D; Fu C; Deng K; Shen A; Wang H; Dai S
    Int J Mol Sci; 2013 Aug; 14(8):16554-69. PubMed ID: 23939428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation.
    Raviv Z; Kalie E; Seger R
    J Cell Sci; 2004 Apr; 117(Pt 9):1773-84. PubMed ID: 15075238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation.
    Duhamel S; Hébert J; Gaboury L; Bouchard A; Simon R; Sauter G; Basik M; Meloche S
    Cancer Res; 2012 Feb; 72(3):626-35. PubMed ID: 22298595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1).
    Dwivedi Y; Rizavi HS; Zhang H; Roberts RC; Conley RR; Pandey GN
    Int J Neuropsychopharmacol; 2009 Nov; 12(10):1337-54. PubMed ID: 19835659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of extracellular signal-regulated kinase (ERK)-1/2 Is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-γ during polymicrobial sepsis.
    Kaplan JM; Hake PW; Denenberg A; Nowell M; Piraino G; Zingarelli B
    Mol Med; 2010; 16(11-12):491-7. PubMed ID: 20809049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na+/K+/Cl- cotransporter activates MAP-kinase cascade downstream to protein kinase C, and upstream to MEK.
    Panet R; Eliash M; Atlan H
    J Cell Physiol; 2006 Mar; 206(3):578-85. PubMed ID: 16222701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ.
    Banks AS; McAllister FE; Camporez JP; Zushin PJ; Jurczak MJ; Laznik-Bogoslavski D; Shulman GI; Gygi SP; Spiegelman BM
    Nature; 2015 Jan; 517(7534):391-5. PubMed ID: 25409143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.
    Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
    Proc Natl Acad Sci U S A; 2008 May; 105(19):6870-5. PubMed ID: 18463290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI.
    Wood P; Mulay V; Darabi M; Chan KC; Heeren J; Pol A; Lambert G; Rye KA; Enrich C; Grewal T
    J Biol Chem; 2011 Jul; 286(26):23077-92. PubMed ID: 21525007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells.
    d'Abramo C; Ricciarelli R; Pronzato MA; Davies P
    J Neurochem; 2006 Aug; 98(4):1068-77. PubMed ID: 16787414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling.
    Roy M; Li Z; Sacks DB
    Mol Cell Biol; 2005 Sep; 25(18):7940-52. PubMed ID: 16135787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
    Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
    Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.